Seven-day triple therapy is a better choice forHelicobacter pylorieradication in regions with low antibiotic resistance

Triple Therapy with High-Dose Proton-Pump Inhibitor, Amoxicillin, and Doxycycline Is Useless forHelicobacter pyloriEradication: A Proof-of-Concept Study

(2014) Nuno Almeida et al.   HELICOBACTER

Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany

(2014) N. Wuppenhorst et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Meta-analysis: Sequential Therapy Appears Superior to Standard Therapy for Helicobacter pylori Infection in Patients Naive to Treatment

(2013) Nadim S. Jafri   ANNALS OF INTERNAL MEDICINE

Association of a probiotic to a Helicobacter pylorieradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study

(2013) Tomás Navarro-Rodriguez et al.   BMC GASTROENTEROLOGY

Antibiotic Resistance ofHelicobacter PyloriIsolated in the Southeast Coastal Region of China

(2013) Peng Su et al.   HELICOBACTER

Clinical effects of Helicobacter pylori outside the stomach

(2013) Francesco Franceschi et al.   Nature Reviews Gastroenterology & Hepatology

Helicobacter pylori research: historical insights and future directions

(2013) Kwong Ming Fock et al.   Nature Reviews Gastroenterology & Hepatology

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate

(2012) Marco Manfredi et al.   HELICOBACTER

Primary Antibiotic Resistance of Helicobacter pylori Isolated from Beijing Children

(2011) Guodong Liu et al.   HELICOBACTER

The New Cooperative Medical Scheme in rural China: does more coverage mean more service and better health?

(2010) Xiaoyan Lei et al.   HEALTH ECONOMICS

CpG Island Hypermethylation of Tumor-Suppressor Genes in H. pylori-Infected Non-Neoplastic Gastric Mucosa Is Linked with Gastric Cancer Risk

(2010) Mitsuru Kaise et al.   HELICOBACTER

The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China

(2010) Wen Gao et al.   HELICOBACTER

Change in Antibiotic Resistance of Helicobacter pylori Strains and the Effect of A2143G Point Mutation of 23S rRNA on the Eradication of H. pylori in a Single Center of Korea

(2010) Tae Jun Hwang et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Should quinolones come first in Helicobacter pylori therapy?

(2010) Marco Berning et al.   Therapeutic Advances in Gastroenterology

A Randomized Clinical Trial to Determine the Efficacy of Regimens Containing Clarithromycin, Metronidazole, and Amoxicillin Among Histologic Subgroups forHelicobacter pyloriEradication in a Developing Country

(2009) Lori Ann Fischbach et al.   HELICOBACTER

Clarithromycin-Amoxycillin-Containing Triple Therapy: A Valid Empirical First-Line Treatment forHelicobacter pyloriEradication in Hong Kong?

(2009) Ivan F.N. Hung et al.   HELICOBACTER

New concepts of resistance in the treatment of Helicobacter pylori infections

(2008) David Y Graham et al.   Nature clinical practice. Gastroenterology & hepatology